Business
PRTC to Present at Morgan Stanley Healthcare Conf
PRTC to Present at Morgan Stanley Healthcare Conf.
About this update from Puretech Health Plc
[{"type":"text","content":"\n \n \n 8 September 2022\n \n \n PureTech Health plc\n \n \n \n \n \n PureTech to Present at the Morgan Stanley Global Healthcare Conference\n \n \n \n \n \n PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (\"PureTech\" or the \"Company\"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced that Daphne Zohar, Founder and Chief Executive Officer, and Julie Krop, M.D., Chief Medical Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York City on Wednesday, September 14, 2022, at 2:05pm EDT. A webcast of the presentation will be available at https://investors.puretechhealth.com.\n \n \n \n \n \n About PureTech Health\n \n \n PureTech is a biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 27 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization and a third that will soon be filed for FDA approval, as of the date of PureTech's most recently filed Half-Year Report and corresponding Form 6-K. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.\n For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.\n \n \n \n Cautionary Note Regarding Forward-Looking Statements\n \n \n This press release contains statements that are or may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation those related to our upcoming presentation at the Morgan Stanley Global Healthcare Conference and our futur...